Skip to main content
Clinical Trials/ISRCTN88611534
ISRCTN88611534
Terminated
未知

Investigating the optimal duration of antibiotic treatment for children with a chronic wet cough

Royal Stoke University Hospital0 sites80 target enrollmentSeptember 28, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Stoke University Hospital
Enrollment
80
Status
Terminated
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 28, 2015
End Date
January 31, 2022
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Royal Stoke University Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\. Aged 6 months to 10 years
  • 2\. Parent reported cough for more than 4 weeks
  • 3\. Doctor observed moist / wet cough

Exclusion Criteria

  • 1\. Gross developmental delay
  • 2\. Cystic fibrosis
  • 3\. Ex\-premature birth (\<36 wks)
  • 4\. Interstitial lung disease
  • 5\. Cardiac abnormalities
  • 6\. Non cystic fibrosis bronchiectasis
  • 7\. Immunodeficiency
  • 8\. Haemoptysis
  • 9\. Penicillin allergy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Optimal duration of antibiotic treatment in patients with complicated parapneumonic pleural effusions or empyemaDuration of antibiotic treatment in complicated parapneumonic pleural effusion and empyema.Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2014-003137-25-ESJosé Manuel Porcel Pérez Hospital Arnau de Vilanova de Lleida Servicio Medicina Interna
Active, not recruiting
Not Applicable
Individualizing duration of antibiotic therapy in hospitalized patients with pneumoniaSubjects with diagnosis of pneumoniaMedDRA version: 14.1Level: LLTClassification code 10035739Term: Pneumonia, organism unspecifiedSystem Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
EUCTR2011-003176-36-ITFONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO DI MILANO892
Active, not recruiting
Phase 1
Assess the optimal duration of pneumonia antibiotic treatmentCommunity Acquired PneumoniaMedDRA version: 20.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01]
EUCTR2017-001406-15-ESFundació Clínic per la Recerca Biomèdica424
Not yet recruiting
Not Applicable
Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteremiaStaphylococcus aureus bacteremia
NL-OMON28621Amsterdam UMC400
Active, not recruiting
Phase 1
Study to determine optimal duration of antibiotic treatment for Staphylococcus aureus bacteremia
EUCTR2019-004921-25-NLAmsterdam UMC396